Fanconi anemia (FA) is an autosomal recessive disease characterized by a variety of congenital abnormalities. Cells from FA patients show chromosomal instability and are hypersensitive to DNA cross-linking agents, though the basic cellular defect in FA is not known. The FANCA gene encodes a protein with an M r of 162 kDa and with unknown function. The cellular localization of the FANCA protein has been controversial, and has been shown in different reports to be exclusively cytoplasmic and predominantly nuclear. In the present study, we further confirm that FANCA localizes primarily to the nucleus. Fusions of FANCA with the green fluorescent protein (GFP) showed a strong nuclear signal and a weak cytoplasmic signal in several cell types. Confocal laser microscopy confirmed that FANCA is evenly distributed throughout the nucleus. We also examined regions in FANCA that participate in its nuclear import. FANCA contains two bipartite nuclear localization signal (NLS) motifs at the extreme N-terminus. Deletion of amino acids N-terminal to the NLS motifs had no effect on the nuclear localization of FANCA or on its ability to correct mitomycin C sensitivity in an FA-A cell line, while deletion of both motifs impeded but did not prevent nuclear import. Deletions of 75, 90 and 150 residues from the N-terminus yielded a mixture of cells with only a cytoplasmic signal, and with both a nuclear and cytoplasmic signal. Deletion of the N-terminal 250 amino acids was required to block nuclear localization completely. Fusion of GFP to the N-terminal 250 amino acids showed a localization pattern similar to FANCA. Mutant forms of FANCA with deletions of the C-terminal 70 or 260 residues localized to the cytoplasm, although the C-terminal 260 amino acids alone lacked NLS activity. The results show that nuclear localization of FANCA involves several functional regions.
INTRODUCTION
Fanconi anemia (FA) is a rare autosomal recessive disorder characterized by a heterogeneous variety of congenital abnormalities (1) . FA patients are predisposed to bone marrow failure and malignancy, in particular acute myelogenous leukemia (AML), though the FA phenotype can exhibit congenital defects involving any major organ system (2) .
Cells from FA patients show marked chromosomal instability (3) and are hypersensitive to DNA cross-linking agents, including mitomycin C (MMC) and diepoxybutane (DEB) (4, 5) . Because of these observations, FA initially was classified as a DNA repair disorder, a category that includes diseases such as xeroderma pigmentosum (XP), ataxia telangiectasia (AT) and other disorders that show sensitivity to radiation or radiomimetic drugs (6) . This characterization of FA has been questioned recently, however, due in part to the cellular and genetic heterogeneity of the FA phenotype (7) .
To date, eight genetic complementation groups (FA-A to FA-H) have been identified (8) . cDNAs from three of these groups, FA-A, FA-C and FA-G, have been cloned (9) (10) (11) (12) . Both FANCA and FANCC lack significant homology to known genes at the nucleotide and protein level, so that the functions of these proteins remain unknown. FANCG is identical to XRCC9, a gene which partially corrects the chromosomal instability phenotype and hypersensitivity to DNA mutagens, including MMC, in CHO UV40 cells (13) . Despite this, the function of FANCG is also unknown, though XRCC9 may be involved in DNA postreplication repair or cell cycle checkpoint control (13, 14) . Studies with FANCC have revealed a role in the prevention of apoptosis, induced by MMC (15) or growth factor deprivation (16) . This observation remains controversial, however, due to conflicting reports that FA-C lymphoblasts (as well as those from FA-A, FA-B and FA-D) die by necrosis when exposed to MMC and show no difference in the levels of apoptotic death compared with normal lymphoblasts (17) .
The FANCA cDNA encodes a protein with a predicted M r of 162 kDa (10, 11) . The protein contains two consensus bipartite nuclear localization signal (NLS) motifs as well as a leucine zipper motif. These characteristics suggest that FANCA could be a nuclear protein. Cellular localization of FANCA has been controversial because of conflicting reports in the literature. The initial report of FANCA localization showed that it was also cytoplasmic (18) . More recently, this has been challenged by studies that show that FANCA is a nuclear protein (19, 20) . In the present study, we show that FANCA is primarily a nuclear protein. Furthermore, we show that localization of FANCA to the nucleus is a complicated process, involving both consensus and non-consensus regions which cooperate with each other to effect full nuclear localization.
RESULTS

FANCA localizes primarily to the nucleus in several cell types
To determine the cellular localization of FANCA, we initially expressed FANCA as a fusion protein with the green fluorescent protein (GFP) in COS-7 cells. We found that with GFP-FANCA the majority of the signal was present in the nucleus, with a comparatively weak signal in the cytoplasm (Fig. 1Ba) . The same result was obtained when GFP-FANCA was transiently expressed in HeLa cells (Fig. 1Bb) and NIH-3T3 cells (Fig. 1Bc) . To verify this result, FANCA was fused to the FLAG epitope and localized in COS-7 cells, probing the fusion protein with an anti-FLAG antibody. The results with FLAG-FANCA were identical to those found with GFP-FANCA (Fig. 1Bd ). Since both of these fusion tags (FLAG and GFP) were fused to the N-terminus of FANCA, where the NLS motifs are located, we verified that the weak cytoplasmic signal was not due to partial obscuring of the bipartite NLS motifs. We constructed a second GFP-FANCA fusion where GFP was on the FANCA C-terminus (FANCA-GFP) and transfected it to COS-7 cells. FANCA-GFP localized predominantly to the nucleus and showed a weak cytoplasmic signal, identical to that of GFP-FANCA (Fig. 1Bf) .
To determine the localization pattern of GFP-FANCA in an FA-A cell line, the GFP-FANCA insert was cloned into the stable episomal expression vector pREP4 and transfected into HSC99 cells. Once hygromycin-resistant cells were recovered (~3 weeks post-transfection), cells were examined for fluorescence. Stable expression of GFP-FANCA in HSC99 lymphoblasts showed a pattern identical to that seen with transient expression in COS-7, NIH-3T3 and HeLa cells (Fig. 1Be) . We had expected individual HSC99 cells to show an equal signal when expressing GFP-FANCA, though only~10% of cells showed detectable green fluorescence. GFP-FANCA was presumably expressed at some level in all cells, based on the ability of GFP-FANCA to correct MMC sensitivity in HSC99 ( Fig. 2; see below) . Detecting expression by fluorescence was hindered by low level autofluorescence of HSC99 cells, so that only transfected cells which fluoresced above background could be detected. Another factor may be that GFP-FANCA was expressed from an episomal vector (pREP4). In stable transfections with pREP4, individual clones were not selected based on expression levels, as they would be with integrated vectors, and it was assumed that expression levels would be equal in individual cells. Our results would argue against this.
Both bipartite NLS motifs are functional in FANCA
GFP was suitable as a marker for studying FANCA localization. Nuclear localization of GFP-FANCA in HSC99 cells correlated with FANCA function, since GFP-FANCA was able to correct MMC sensitivity in HSC99 cells ( Fig. 2 ; see below). As a model for examining motifs that function in nuclear localization of FANCA, COS-7 cells were chosen, since (i) COS-7 cells transfected with higher efficiencies than HSC99 cells and (ii) GFP-FANCA showed the same cellular localization pattern as that seen in HSC99 cells. Regions of FANCA were deleted and the FANCA mutants were localized as GFP fusions. A summary of the FANCA mutant forms and the localization patterns observed is shown in Figure 3 .
The function of the overlapping bipartite NLS motifs was examined initially. The bipartite NLS motif has the consensus sequence B2-N(10-12)-B(3-4 of 5), where B is a basic amino acid (usually arginine or lysine) and N is any amino acid, at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from though proline residues are common (21) . To test the ability of the bipartite NLS motifs to localize FANCA to the nucleus, we deleted the N-terminal 35 amino acids, removing both NLS motifs (residues 18-34 and 19-35) as well as the initial 17 amino acids. Transient expression of this mutant FANCA, called FA35, as a GFP fusion in COS-7 cells revealed a homogeneous signal throughout the cell (Fig. 4Bc) . We then tested the ability of each of the NLS motifs to function individually. Two FANCA mutants were made, each with one functional NLS. Each NLS mutant had a deletion of amino acids N-terminal to the functional NLS. We did this to verify that the effect of deleting the NLS motifs in mutant FA35 was due to deletion of only the NLS motifs and not due to deletion of residues Nterminal to these motifs. In addition, this step also allowed us to determine the effect of removing these amino acids on nuclear localization and function of FANCA (see below). To examine the function of the 18-34 residue NLS, a combination of deletion and site-directed mutagenesis was used to delete the N-terminal 17 amino acids and to mutate the arginine residue at position 20 (codon AGG) to glycine (codon GGG). This mutant, FA18/34, was fused to GFP and expressed in COS-7 cells. GFP-FA18/34 showed a primarily nuclear localization, revealing that the 18-34 residue NLS alone is functional (Fig.  4Ba) . To test the function of the 19-35 residue motif, the Nterminal 18 amino acids were deleted (mutant FA19/35). GFP-FA19/35 also localized to the nucleus, similarly to FANCA and FA18/34 (Fig. 4Bb) .
The results indicated that the N-terminal 17 amino acids of FANCA do not function in its cellular localization, and that both of the bipartite NLS motifs can function independently in nuclear localization. To examine the effect of mutations within the bipartite NLS motifs in correcting MMC sensitivity in FA-A cells, stable lines of HSC99 expressing GFP-FA18/34 and GFP-FA35 were derived as described above for GFP-FANCA. Because MMC sensitivity of HSC99 is corrected with expression of FANCA from pREP4 (unpublished data), we tested the ability of GFP-FANCA to correct MMC sensitivity of HSC99 using the stable transfectants. GFP-FANCA was able to correct MMC sensitivity in HSC99 cells, indicating that the presence of GFP (M r 27 kDa) on the FANCA N-terminus has no effect on FANCA function (Fig. 2) . Results from MMC viability curves of cells transfected with the FANCA (Fig. 5a ). Deletion of 90 amino acids (mutant FA90) gave a localization pattern identical to that of FA75 (Fig. 5b) . Deletion of 150 amino acids (mutant FA150) gave predominantly cells with a cytoplasmic signal alone, while~10% of cells showed a nuclear/cytoplasmic signal (Fig. 5c ). Deletion of 250 amino acids gave only cells with a cytoplasmic signal (mutant FA250; Fig. 5d ). Residues 36-250 therefore participate with the bipartite NLS motifs to effect FANCA nuclear localization.
The N-terminal 250 residues of FANCA confer nuclear localization activity
The N-terminal deletion experiments showed that the N-terminal 250 amino acids are crucial for FANCA nuclear localization. To verify that this region has NLS activity, the N-terminal 250 amino acids of FANCA (called N250) were fused to GFP and expressed in COS-7 cells. GFP-N250 localized primarily to the nucleus, similarly to GFP-FANCA (Fig. 5e ), indicating that NLS activity in FANCA is cooperative between the bipartite NLS motifs and residues 36-250. An identical result was obtained when GFP-N250 was expressed in HeLa cells (data not shown).
Confocal imaging of COS-7 cells expressing GFP-FANCA and N-terminal mutants was done to examine the distribution of these proteins within the cell. FANCA was present throughout the nucleus and not merely accumulated at the surface of the nucleus, an effect which can be difficult to distinguish by epifluorescence (Fig. 6a) . The signal was distributed evenly throughout both cellular compartments, but was absent from the nucleoli. The homogeneous distribution of FA35 and FA75 thoughout the nucleus and cytoplasm was verified by confocal imaging (Fig. 6b and c) . The complete lack of nuclear signal in FA250 by confocal imaging was also consistent with the epifluorescence data (Fig. 6d) . 
Deletions in the FANCA C-terminus block nuclear localization
Deletion of the FANCA C-terminus had a dramatic effect on cellular localization. Deletion of either the C-terminal 70 (mutant FASAC) or 260 (mutant FASMA) amino acids prevented nuclear localization in COS-7 cells, despite the presence of an intact N-terminus ( Fig. 7a and b, respectively) . The NLS activity of the FANCA N-terminus is therefore blocked when the C-terminus is mutated. The signal produced by FASMA and FASAC was evenly distributed throughout the cytosol, similarly to the N-terminal deletion mutant FA250. Fusion of the Cterminal 260 amino acids (called C260) to GFP failed to localize to the nucleus (Fig. 7c) . The molecular weight of the GFP-C260 fusion protein (~57 kDa) is at the cut-off point for passive diffusion into the nucleus (see Discussion) and should enter the nucleus through an active import mechanism, so its presence in the cytoplasm indicates that the FANCA C-terminus lacks NLS activity. By comparison, GFP expressed in COS-7 cells distributes throughout the nucleus and cytoplasm (Fig. 7d) , since GFP (M r 27 kDa) is able to diffuse passively into and out of the nucleus in mammalian cells (22) .
DISCUSSION
Import of proteins into the nucleus occurs through nuclear pore complexes (reviewed in refs 23, 24) . Proteins with an M r less than~60 kDa are able to diffuse passively through these pores (25) , while larger proteins and some small nuclear proteins such as histones are imported actively through an energyrequiring multistep process (26, 27 ). An early step in nuclear import is the interaction of the importin-α/β heterodimer with NLS motifs (28, 29) . The majority of NLS motifs fall into two categories, each of which is dependent on the presence of basic amino acids: a single cluster NLS, patterned after the SV40 large T antigen (PKKKRKV), and the bipartite NLS which derives from the Xenopus nuclear protein nucleoplasmin (21) . FANCA contains bipartite consensus NLS motifs, both of which are functional. In addition to a role in nuclear import, the bipartite NLS motifs are necessary for the correction of MMC sensitivity in HSC99 cells. We show that deletion of these motifs impedes but does not prevent nuclear localization of FANCA. This localization pattern, in which there is a cooperative effect among localization signals, has been seen for other nuclear proteins, including the yeast ribosomal protein L29 (30) , the retinoblastoma tumour suppressor (31) and polyoma large T antigen (32) . Recently, Näf et al. (19) also reported that the NLS motifs in FANCA are functional. In contrast to our results, however, that study showed that mutagenesis of the bipartite NLS motifs in FANCA completely blocked its import into the nucleus. This was found both when the NLS motifs were deleted and also when all the basic residues in the NLS motifs were mutagenized (19) . One possible explanation for the differences in our findings is the use of different cell lines in the two studies. Näf et al. performed their localization experiments in the FA-A fibroblast cell line GM6914, whereas we have used both COS-7 cells and the FA-A lymphoblast cell line HSC99. The influence of the cell lines used to examine FANCA localization is an important consideration, since wildtype FANCA fails to localize to the nucleus in 293 cells (18) . These studies reveal that nuclear uptake of FANCA is apparently a very complicated process. Presumably, identification of the factors which affect nuclear localization of FANCA will probably resolve these discrepencies.
The bipartite NLS motifs in FANCA participate with a region spanning residues 36-250 to effect full nuclear localization. This secondary region may therefore interact with another protein which contains a consensus NLS, or the region itself may contain one or more non-consensus NLS motifs. Several examples of proteins with NLS sequences that do not conform to the two predominant paradigms have been identified, including the HIV-1 Tat protein (33), the yeast homeodomain protein Matα2 (34) and the heat shock protein hsc70 (35) . Nuclear import of these proteins is believed to occur by a mechanism distinct from that mediated by importin. If FANCA localizes to the nucleus via the importin pathway, its import is modified by residues 36-250, presumably due to interaction of this region with other proteins.
Deletions within residues 36-250 show an unusual effect, where a proportion of cells shows impaired nuclear localization of FANCA, while in other cells nuclear import of FANCA is blocked. To our knowledge, this is the first report of a nuclear protein which shows this particular kind of mixed localization pattern when NLS motifs are deleted. Protein import into the nucleus has been described as a stochastic process (36) which has several levels of regulation, one of which is protein phosphorylation (reviewed in ref. 37) . For example, the rate of nuclear accumulation of the SV40 large T antigen is increased significantly by phosphorylation at two sites [for casein kinase II (38) and double-stranded DNA-dependent kinase (39) ] which flank the T antigen NLS. This observation may also apply to FANCA, since it was shown recently that FANCA is phosphorylated and that phosphorylation is necessary for its nuclear accumulation (40) . The sites at which FANCA is phosphorylated as well as the kinases involved are not known. However, the localization results observed with the FANCA deletion mutants FA35, FA75, FA90 and FA150 suggest that phosphorylation sites may reside in the FANCA Nterminus, and that deleting these sites causes the mixed localization patterns seen. Our interpretation of the results with FANCA is that deletions within residues 36-250 severely impair nuclear uptake, more so than deletion of only the bipartite NLS motifs, and that the degree of nuclear uptake is proportional to the amount of this region that is present. FANCA may therefore be an important model system for examining the kinetics of protein import into the nucleus.
Deletions within the FANCA N-and C-termini have the same effect on nuclear localization, though distinct functional roles can be attributed to each region. The N-terminal 250 residues duplicate the cellular localization pattern shown by wildtype FANCA, while the C-terminal 260 residues have no NLS activity. Furthermore, deletions within the C-terminus counteract the NLS activity demonstrated by the N-terminus. The mutated C-terminus may interfere with binding of the N-terminus to importin-α/β. Binding of the NLS motif to importin is followed by docking at the nuclear pore complex (41, 42) . Because C-terminal deletion mutants FASAC and FASMA are distributed throughout the cytoplasm, rather than accumulated at the nuclear membrane, this suggests that nuclear uptake of these mutants may not be initiated. Alternatively, deletions within the C-terminus may expose cytoplasmic retention domains which are concealed in the intact and properly folded protein. Neither of these explanations, however, implies a role for the C-terminus within the intact FANCA, suggesting that the C-terminus does not play a significant part in the FANCA nuclear import process.
In conclusion, we have shown that the FANCA protein is primarily nuclear within the cell, and that its import into the nucleus is influenced by several regions within the N-and C-termini. Although the intracellular roles of the FA proteins remain unknown, the broad cellular phenotypes demonstrated by FA at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from cells indicate that diverse processes within the cell, which until recently have been thought to act independently, may interact to maintain cellular homeostasis. Defects in cellular pathways, including apoptosis (15, 43) , cell cycle phases (44, 45) and processing of DNA mutations (46) , have been identified in FA cells. Until recently, the presence of an FA protein in the nucleus would have been consistent with a direct role in the maintenance of chromosomal stability, such as DNA repair. However, it has become clear, in particular through the analysis of FANCC, that FA involves several cellular processes. Although cloning of FA genes has made it possible to correlate some of these abnormalities with the expression of specific genes, the genetic heterogeneity in FA prevents a simple explanation, or even description, of the FA phenotype. Further cloning of FA genes and characterization of FA proteins, including cellular localization, should finally elucidate the cellular mechanisms within this complicated disorder.
MATERIALS AND METHODS
Cell lines and media
HeLa, COS-7 and NIH-3T3 cells were cultured in Dulbecco's modified Eagle's medium (DMEM; high glucose) (Life Technologies, Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS). The lymphoblast cell line HSC93 (normal control) and the FA-A cell line HSC99 were cultured in RPMI-1640 (Bio-Whittaker, Walkersville, MD) supplemented with 10% FBS.
FANCA expression constructs
The FANCA cDNA, originally cloned as a 5.5 kb insert in mammalian expression vector pREP4 (10), was cloned into the NotI site in pBluescript (Stratagene, La Jolla, CA). This construct, called pBS-FANCA, was used as the source FANCA for subsequent plasmid constructs as well as the source of template for PCR reactions. GFP-FANCA fusion constructs were made in the vector pEGFP-C1 for N-terminal GFP fusions or pEGFP-N1 for the C-terminal GFP fusion (Clontech, Palo Alto, CA). FANCA mutants were constructed by PCR amplification of portions of the reading frame to make in-frame fusions with GFP. PCR products were generated with 20 cycles of amplification using Pwo DNA polymerase (Roche Diagnostics, Indianapolis, IN). Construct pGFP-FANCA, which expresses N-terminal GFP fused to full-length FANCA (lacking only the initiating ATG), was made as follows: the 5' end of the FANCA open reading frame (ORF) was rebuilt by PCR by amplifying the 5' end with sense primer FAA (5'-ACAGAATTCATCCGACTCGT-GGGTCCCGAACTC-3') and antisense primer NSI (5'-CACAG-CATGCATGTCGGGAT-3'). The resulting product was exchanged with the 5' end of the FANCA ORF (digested with NsiI) and this rebuilt ORF was cloned into pEGFP-C1 digested with EcoRI and SacII. In a similar manner, the N-terminal deletion constructs were made using primer NSI and the following sense primers for each deletion mutant: pFA18/34, 5'-CAGACAAAGCTTGAATTCTCGGAGGGCCTGGGCCGAG CTG; pFA19/35, 5'-ACAATAAAGCTTGAATTC44TCGCC-GGGGGGCCTGGGCCGAG; pFA35, 5'-CAGACAAAGCTT-GAATTCTAATCCTGAAAGGGCACAGAAA; pFA75, 5'-ACAAAGCTTGAATTCTAAAGTGATTGACTG-TGACAGT; pFA90, 5'-ACAATAAAGCTTGAATTCTAGT-TCATTTATAGGCTCTGCT; and pFA150, 5'-ACAAAGCTT-GAATTCTTTTGCTCAGTATTTATTGGCA. pFA250 was made by amplifying the 5' end of the FANCA ORF with primer FA250 (5'-ACAATAAAGCTTGAATTCTTCAGATCTGAGA-AGAACTGTG) and antisense primer NDE (5'-ACCAGTCT-GCATATGACAGGAACG). The product was digested with EcoRI-NdeI and exchanged with the 5' end of the FANCA ORF, digested with NdeI. All FANCA N-terminal deletion mutant inserts were cloned into a modified version of pEGFP-C1, called pEGFP-C1Nh, in which an NheI site was added to the multiple cloning site to facilitate subsequent cloning of GFP-FANCA inserts as NheI inserts in pREP4.
The FANCA C-terminal deletion mutant pFASMA was made by digesting pGFP-FANCA with SmaI. The fragment containing the vector and FANCA insert up to the SmaI site was recovered and religated. To make pFASAC, pBS-FANCA was first digested with SacI and the 3' end of the insert was discarded. A SacII site was introduced at the SacI site, and thẽ 2.8 kb KpnI-SacII insert was exchanged with the KpnI-SacII insert in pGFP-FANCA.
Construct pFLAG-FANCA, which expresses full-length FANCA with an N-terminal FLAG epitope, was made by cloning the EcoRI-SacII insert from pBS-FANCA into the FLAG expression vector pFLAG-CMV2 (Kodak, New Haven, CT). pBS-FANCA was digested with SacII, blunted with Klenow, digested with EcoRI, and the insert cloned as an EcoRI-blunt fragment into pFLAG-CMV2 digested with EcoRI-SmaI. Construct pFANCA-GFP expresses GFP on the FANCA C-terminus. To make this construct, the intermediary construct pBSFAA3SH was made by amplifying the 3' end of the FAA ORF with the sense primer FAASAC (see above) and FAA3SH (5'-CGTGAGCTCAAGCTT-GAAGAGATGAGGCTCCTGGGA). The PCR product was digested with SacI, then exchanged for the two C-terminal SacI fragments in pBS-FANCA. The insert was then cloned as a HindIII insert into pEGFP-N1.
Construct pGFP-N250, which expresses GFP fused to the N-terminal 250 amino acids of FANCA, was made by amplifying the FANCA N-terminus with primers FAA (see above) and 3C1-250 (5'-ATAGAATTCGAGTTTTTCTGAAATCCCCTCAAAAC). The product was digested with EcoRI and cloned into pEGFP-C1. Construct pGFP-C260, which expresses GFP fused to the C-terminal 260 amino acids of FANCA, was made by amplifying the C-terminus with primers 5C260/B (5'-ACAATAGGATC-CCCCGAACTGCAGAAGCTACAAGAA) and 3C260/B (5'-ATCACAGGATCCGAAGAGATGAGGCTCCTGGGA). The product was digested with BamHI and cloned into pEGFP-C1.
Stable expression constructs were made with the mammalian episomal expression vector pREP4 (Invitrogen, Carlsbad, CA). To make construct pRGFANCA, which expresses GFP-FANCA in pREP4, pGFP-FANCA was digested with SacII, blunted with Klenow and ligated with phosphorylated NheI linkers (Stratagene). GFP-FAA was then excised as an NheI insert and cloned into pREP4. For constructs pRGFA18/34 and pRGFA35, GFP-FA18/34 and GFP-FA35 inserts were removed from constructs pFA18/34 and pFA18, respectively, by digestion with NheI, and cloned into pREP4 digested with NheI.
PCR-generated regions in expression constructs were verified for sequence fidelity by cycle sequencing with the ABI at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from 377 DNA sequencer and the Big Dye terminator kit using dyelabelled ddNTPs (ABI), or the LI-COR Long Read IR4200 (LI-COR, Lincoln, NE) with fluorescent-labelled primers and Sequitherm Excel (Epicentre, Madison, WI).
Transient expression of FANCA
COS-7, HeLa and NIH-3T3 cells were transfected with Lipofectamine Plus (Life Technologies). Cells were seeded in LabTek chamber slides (Nalge Nunc International, Rochester, NY) at a density of 1 × 10 5 cells and cultured overnight prior to transfection. Cells were overlaid with 2 µg of plasmid DNA pre-mixed with 3 µl of Plus reagent and 2 µl of lipofectamine in DMEM without FBS. At 3 h following the start of transfection, DMEM with FBS was added (final 10% FBS). Duplicate slides were seeded for each transfection, and transfections were observed after 48 h.
Stable expression of GFP-FANCA in lymphoblasts
HSC99 and HSC93 lymphoblasts were transfected by electroporation. Cells (8 × 10 6 ) were washed in electroporation buffer (15 mM potassium phosphate, 1 mM MgCl 2 , 272 mM sucrose, 10 mM HEPES, pH 7.4) then resuspended in 200 µl of the same buffer. DNA was added to the cells at a concentration of 0.2 µg/10 6 cells and the mixture was transferred to an electroporation cuvette (0.2 cm electrode distance). Electroporation was performed with the Gene Pulser II RF module (Bio-Rad, Hercules, CA). Cells were incubated on ice for 10 min prior to electroporation, then pulsed at 250 V (40 kHz RF frequency) for five pulses with a 2 ms burst duration and a 0.1 s burst interval. After electoporation, cells were transferred to RPMI with 10% FBS. Three days after transfection, medium supplemented with 200 µg/ml hygromycin B (Calbiochem, San Diego, CA) was added and cells were cultured for 10 days. Viable cells were recovered with Lymphoprep Medium (Life Technologies). Cells were cultured in the presence of hygromycin B to maintain the expression constructs. At 1-2 weeks following the addition of hygromycin B, cells were tested for MMC sensitivity (see MMC viability curve below).
Microscopic examination of cells
Transfected lymphoblasts (~5 × 10 4 cells) were centrifuged onto microscope slides for 1 min at 1000 r.p.m. using a Cytospin 3 (Shandon Scientific, Cheshire, UK). Transfected COS-7 and HeLa cells were processed directly as adherent cells. Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min and washed three times with PBS. Cell nuclei were visualized by staining with 4',6-diamidino-2-phenylindole (DAPI; Sigma, St Louis, MO) at a concentration of 2 µg/ml for 30 min, followed by destaining with PBS for 30 min. Cells transfected with GFP constructs were examined without further processing. To detect FLAG-FANCA in transfected cells, cells were permeabilized with methanol (pre-chilled to -20°C) for 2 min, then washed with PBS three times for 10 min per wash. Cells were incubated with anti-FLAG mouse monoclonal antibody M2 (Kodak) at a dilution of 1:100 in 10% normal goat serum (Sigma) overnight at 4°C. Cells were washed with PBS and incubated with goat anti-mouse secondary antibody conjugated to fluorescein isothiocyanate (FITC; Jackson Immunoresearch, West Grove, PA) diluted 1:100 in 10% goat serum. Fluorescence microscopy was done using a Leitz Aristoplan microscope (Wild Leitz, Wetzlar, Germany) with a mercury lamp. Both GFP-transfected and FITC-stained cells were visualized with a blue filter block (excitation range 450-480 nm), while DAPI-stained cells were visualized with a UV filter block (excitation range 340-380 nm). Approximately 100 fluorescent cells were examined in two independent tranfections. Cells were viewed at 400× magnification.
Laser scanning confocal fluorescence microscopy was done with a Leica DM IRB microscope (Leica Microsystems, Heidelberg, Germany) using an argon/krypton laser (Omnichrome, Chino, CA). Sections (~1 µm) were taken starting from the top of the cell. Cells were examined at 630× magnification.
MMC viability curves
Cells (10 5 /ml) transfected with recombinant pREP4/GFP-FANCA plasmid constructs were seeded in 24-well plates. Medium supplemented with MMC (Roche Diagnostics) was added at concentrations up to 300 nM. After 8 days, cells were counted using a Coulter Counter (Beckman Coulter, Fullerton, CA). Cell counts were plotted against MMC concentration using CA Cricket Graph III (Computer Associates International, Islandia, NY). 
